Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Online pharmacy still open despite counterfeit allegations

Lauren Vogel
CMAJ August 08, 2017 189 (31) E1023-E1024; DOI: https://doi.org/10.1503/cmaj.1095461
Lauren Vogel
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

The founder of CanadaDrugs.com and five others associated with the online pharmacy are wanted for prosecution in the United States for selling unapproved and counterfeit medicines to American doctors, but a decision on their extradition may be months away.

CanadaDrugs’ president and founder, Kristjan Thorkelson, is set to appear in Manitoba’s top court for a pretrial conference on Aug. 22. Joining him will be Ronald Sigurdson (chief financial officer), Darren Chalus (director of clinical sales), Troy Nakamura (clinical manager) and Thomas Haughton (president of two CanadaDrugs’ subsidiaries). British Columbia’s Supreme Court has adjourned the case of a sixth man, James Trueman, until early September.

Once hearings are scheduled, “it could take several weeks or even months” before the courts decide whether there is sufficient evidence to extradite the men, said Ian McLeod, media relations adviser with the Department of Justice. “The time it takes to complete an extradition hearing depends on a number of factors, including whether the hearing will be contested.”

Lawyers for the men declined to comment, but Joe Weinstein, who is representing Chalus, stated “we will be fighting the request for extradition.”

In the meantime, CanadaDrugs remains open for business and licensed by both Health Canada and the College of Pharmacists of Manitoba. In a statement, the college said it is watching the court proceedings “carefully,” but claimed that “pharmacies licensed by the college are safe.”

Health Canada suspended CanadaDrugs’ license to sell wholesale prescription drugs in 2014, citing “significant concerns” with manufacturing processes. However, that license was reinstated in 2016 following an inspection.

Figure

CanadaDrugs.com remains open for business as its executives face a potentially lengthy extradition battle.

Image courtesy of iStock/18percentgrey

Both Health Canada and Manitoba’s college of pharmacists have tended to turn a blind eye to violations of Canadian and American laws by Internet pharmacies, said Amir Attaran, a professor of law and medicine at the University of Ottawa. “Health Canada has refused for years to prosecute any criminal Internet pharmacies,” he said. Meanwhile, the college continues to collect fees and license them. For this, “its officials could — and I strongly believe should — be indicted for conspiracy in the US.”

SafeMedicines.org reports that CanadaDrug previously boasted on its website of selling imported drugs to Americans since 2001. Now, the company’s terms of sale state that “virtually all shipments of prescription drugs imported from an international pharmacy by a United States customer will violate United States law.”

The US Food and Drugs Administration began investigating the company in 2012 after it sold at least one American physician fake cancer drugs containing no active ingredients, according to a 2014 indictment.

Prosecutors allege CanadaDrugs illegally imported and sold US$78 million in unapproved, mislabeled, contaminated or counterfeit medicines to Americans. They also accuse the company of falsifying customs declarations and improperly storing drugs.

In emails provided to Manitoba’s top court and authenticated by Microsoft, Trueman was notified that a physician returned two units of Dysport (a form of botulinum toxin A that blocks nerve activity in muscles) because the cold packs shipped with the product were warm. He responded, “Just put in freezer they will be ok.”

US investigators also taped a conversation in which a CanadaDrugs affiliate told a cancer clinic employee that “the drugs we sold were never FDA approved … That is why you are able to get the prices you are getting.”

Thorkelson and his associates are charged with smuggling, conspiracy and international money laundering. If convicted, they could face 20 years in prison and fines.

Two Americans have already pleaded guilty in the case and are expected to testify at the US trial, along with a third man whose charges were dropped in exchange for his testimony.

Footnotes

  • Posted on cmajnews.com on July 17, 2017.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (31)
CMAJ
Vol. 189, Issue 31
8 Aug 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Online pharmacy still open despite counterfeit allegations
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Online pharmacy still open despite counterfeit allegations
Lauren Vogel
CMAJ Aug 2017, 189 (31) E1023-E1024; DOI: 10.1503/cmaj.1095461

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Online pharmacy still open despite counterfeit allegations
Lauren Vogel
CMAJ Aug 2017, 189 (31) E1023-E1024; DOI: 10.1503/cmaj.1095461
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Resignations at Canada’s drug pricing panel raise independence questions
  • Provinces accept federal health funding deal
  • Feds propose $196B health funding deal with few strings attached
Show more News

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire